Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study
PaperCitations, authors & open-access status
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 36 citations, 2022 year and gold oa status.
36
Citations
2022
Year
gold
OA Status